C3 glomerulopathy: ten years' experience at Mayo Clinic
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - Elsevier
Objective To describe the clinicopathological features, complement abnormalities, triggers,
treatment, and outcomes of C3 glomerulopathy. Patients and Methods A total of 114 patients …
treatment, and outcomes of C3 glomerulopathy. Patients and Methods A total of 114 patients …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - search.proquest.com
Furthermore, treatment outcomes were defined based on a previous study by Rabasco et
al11:(1) complete remission (CR) was defined as estimated glomerular filtration rate (eGFR) …
al11:(1) complete remission (CR) was defined as estimated glomerular filtration rate (eGFR) …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
A Ravindran, FC Fervenza… - Mayo Clinic …, 2018 - mayoclinicproceedings.org
Objective To describe the clinicopathological features, complement abnormalities, triggers,
treatment, and outcomes of C3 glomerulopathy. Patients and Methods A total of 114 patients …
treatment, and outcomes of C3 glomerulopathy. Patients and Methods A total of 114 patients …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
A Ravindran, FC Fervenza… - Mayo Clinic …, 2018 - mayoclinic.elsevierpure.com
Objective: To describe the clinicopathological features, complement abnormalities, triggers,
treatment, and outcomes of C3 glomerulopathy. Patients and Methods: A total of 114 …
treatment, and outcomes of C3 glomerulopathy. Patients and Methods: A total of 114 …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - europepmc.org
Results The mean age at diagnosis for the entire cohort was 40.4±22.3 years, with a median
serum creatinine level and proteinuria value of 1.6 mg/dL (range: 0.3-14.7)(to convert to …
serum creatinine level and proteinuria value of 1.6 mg/dL (range: 0.3-14.7)(to convert to …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - iro.uiowa.edu
To describe the clinicopathological features, complement abnormalities, triggers, treatment,
and outcomes of C3 glomerulopathy. A total of 114 patients with C3 glomerulopathy seen at …
and outcomes of C3 glomerulopathy. A total of 114 patients with C3 glomerulopathy seen at …
[HTML][HTML] C3 Glomerulopathy: 10-Years Experience at the Mayo Clinic
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - ncbi.nlm.nih.gov
C3 Glomerulopathy: 10-Years Experience at the Mayo Clinic - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective To describe the clinicopathological features, complement abnormalities, triggers,
treatment, and outcomes of C3 glomerulopathy. Patients and methods A total of 114 patients …
treatment, and outcomes of C3 glomerulopathy. Patients and methods A total of 114 patients …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - go.gale.com
Objective: To describe the clinicopathological features, complement abnormalities, triggers,
treatment, and outcomes of C3 glomerulopathy. Patients and Methods: A total of 114 …
treatment, and outcomes of C3 glomerulopathy. Patients and Methods: A total of 114 …
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
A Ravindran, FC Fervenza, RJH Smith… - Mayo Clinic …, 2018 - iro.uiowa.edu
To describe the clinicopathological features, complement abnormalities, triggers, treatment,
and outcomes of C3 glomerulopathy. A total of 114 patients with C3 glomerulopathy seen at …
and outcomes of C3 glomerulopathy. A total of 114 patients with C3 glomerulopathy seen at …